Introduction
============

As human immunodeficiency virus (HIV)--infected persons are surviving to older ages, the spectrum of causes of death among them is changing---the proportion of deaths in which HIV infection was the underlying cause has decreased, while the proportion of deaths due to causes not clearly attributable to HIV has increased \[[@ref1]-[@ref3]\]. Retention in medical care and effective treatment to achieve a suppressed viral load are essential to reduce morbidity and mortality, as well as the potential for onward transmission of the virus \[[@ref4]\]. However, little information is available about care and outcomes before death among persons living with HIV who eventually died of either HIV-attributable or other causes. Assessment of predeath care by cause of death can inform opportunities for intervention. This study is an update on a recent study that examined HIV care within the year before death \[[@ref5]\]. We expanded the investigation to compare HIV-infected persons who died of an HIV-attributable underlying cause with those who died of another underlying cause with respect to (1) disease stage within 12 months before death and (2) measures of care in terms of frequency of CD4 T-lymphocyte counts or viral load measurements and viral suppression.

Methods
=======

All US states and the District of Columbia require reporting of cases of HIV infection to their health departments; however, not all have mandatory reporting of all values of CD4 T-lymphocyte cell counts and viral load test results by laboratories. We used data reported to the National HIV Surveillance System (NHSS) of the Centers for Disease Control and Prevention through July 2015 from 13 jurisdictions with mandated laboratory reporting of all results from HIV-related tests to their HIV surveillance programs and that also collected cause of death information (California, District of Columbia, Hawaii, Iowa, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, South Carolina, Texas, West Virginia). The analysis was restricted to persons who died in 2012, were ≥13 years old at the time of death, and resided in the selected areas at both diagnosis and death. The purpose of the residential restriction was to enhance the completeness of data on laboratory test results, because laboratories report test results to the health departments of the jurisdictions corresponding to the patient's residential address reported by the health care provider. Among the health departments of these 13 jurisdictions, at least 85% of the deaths they reported to NHSS had data on the underlying cause, which they obtained by linking HIV surveillance data with either state or local vital records data or the National Death Index. The health departments reported the data to NHSS without key personal identifiers (eg, name, Social Security number) that they used to link HIV cases to death records and laboratory test results. Causes of death were identified by codes in the *International Classification of Diseases, Tenth Revision (ICD-10)* \[[@ref6]\]. We classified a death as "HIV-attributable" if the reported underlying cause was HIV infection, indicated either explicitly (by an ICD code for HIV infection itself) or implicitly (by an ICD code for an AIDS-defining opportunistic illness or immunodeficiency---cell-mediated or unspecified type, not an antibody-mediated or congenital type). We assumed HIV infection was underlying an opportunistic illness or immunodeficiency because all the decedents had HIV infection reported to NHSS, even if HIV was not mentioned on the death certificate. If the underlying cause was known but was not HIV infection, we classified the death as "non--HIV-attributable death" (and the underlying cause as "other" than HIV infection; [Multimedia Appendix 1](#app1){ref-type="supplementary-material"}). Persons missing information on underlying causes of death were excluded from the analyses. Stage of disease was based on the most recent CD4 cell count or percentage, and was defined in a reversible way, so that a person whose HIV disease had previously met the criteria for stage 3 (AIDS) could be reclassified in stage 1 if the most recent CD4 cell count was ≥500 cells/µL \[[@ref7]\]. Persons were considered to be "in care" within 12 months before death if they had ≥1 CD4 or viral load test result in that period and "in continuous care" if they had ≥2 CD4 or viral load test results at least 3 months apart within the last 12 months before death \[[@ref8]\]. Viral suppression (defined as \<200 copies/mL) was based on the most recent viral load in the 12 months before death.

We assessed indicators overall and by sex, age, race/ethnicity, and transmission category (male-to-male sexual contact, ie, men who had sex with men or MSM; injection drug use; MSM and injection drug use; heterosexual contact; and other). We also determined care and viral suppression by disease severity (whether a person's infection had ever been classified as stage 3 disease, AIDS), the length of time since diagnosis of HIV infection, and urban versus rural area of residence at the time of diagnosis (metropolitan statistical area population ≥500,000; metropolitan statistical area population 50,000-499,999; and nonmetropolitan population \<50,000). Using log-binomial regression, we calculated prevalence ratios and 95% CIs to determine statistical differences on measures of care between persons who died of HIV-attributable underlying causes and those who died of non--HIV-attributable underlying causes. To control for potential confounding covariates, the analyses were adjusted for sex, age at death, race/ethnicity, transmission category, and ever AIDS. Analyses were adjusted for missing risk factor information. Analyses were performed using SAS version 9.3 statistical software (SAS Institute Inc), with the GenMod procedure for the log-binomial regression.

Results
=======

Among 6594 persons who died in 2012 with diagnosed HIV infection, 48.88% (3223/6594) died of HIV-attributable underlying causes and 51.12% (3371/6594) died of non--HIV-attributable underlying causes. Of those who died of HIV-attributable causes, most were male (2374/3223, 73.66%) and ≥40 years old at death (2673/3223, 82.94%); their racial/ethnic distribution was 47.35 % (1526/3223) non-Hispanic black or African American, 23.30% (751/3223) non-Hispanic white, 22.25% (717/3223) Hispanic or Latino, and 7.11% (229/3223) other; 40.80% (1315/3223) were MSM ([Table 1](#table1){ref-type="table"}). Among those who died of non--HIV-attributable causes, most were male (2493/3371, 73.95%) and ≥40 years old at death (3064/3371, 90.89%); their racial/ethnic distribution was 45.57% (1536/3371) non-Hispanic black or African American, 29.01% (978/3371) non-Hispanic white, 18.30% (617/3371) Hispanic or Latino, and 7.12% (240/3371) other; 36.78% (1240/3371) were MSM ([Table 2](#table2){ref-type="table"}). Overall, the percentage of persons with late-stage disease (stage 3, AIDS, based on the most recent indicator, ie, CD4 test or opportunistic illness diagnosis) in the 12 months before death was more than twice as great among persons who died of HIV-attributable causes (65.28%, 2104/3223; [Table 1](#table1){ref-type="table"}) as among persons who died of non--HIV-attributable causes (30.88%, 1041/3371; [Table 2](#table2){ref-type="table"}). The percentage with stage 3 disease was similarly higher in almost all demographic groups and transmission categories of persons who died of HIV-attributable causes than in their counterparts who died of other causes.

###### 

Most recent stage of disease within 12 months before death, among persons aged ≥13 years who died of HIV-attributable causes in 2012, in 13 US jurisdictions.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Decedent characteristics                  Most recent stage^a^ of disease before HIV-attributable death^b^                                                                 
  ----------------------------------------- ------------------------------------------------------------------ ------ ------ ----- ------ ------ ------ ------ ------ ------ ------
  Total                                     3223                                                               100    244    7.6   542    16.8   2104   65.3   333    10.3   

  **Sex**                                                                                                                                                                    

  \                                         Male                                                               2374   73.7   175   7.4    394    16.6   1543   65.0   262    11.0

  \                                         Female                                                             849    26.3   69    8.1    148    17.4   561    66.1   71     8.4

  **Age (years) at death, year-end 2012**                                                                                                                                    

  \                                         13-29                                                              154    4.8    7     4.5    18     11.7   121    78.6   8      5.2

  \                                         30-39                                                              396    12.3   8     2.0    40     10.1   321    81.1   27     6.8

  \                                         40-49                                                              914    28.4   58    6.3    112    12.3   666    72.9   78     8.5

  \                                         50-59                                                              1107   34.3   90    8.1    201    18.2   681    61.5   135    12.2

  \                                         ≥60                                                                652    20.2   81    12.4   171    26.2   315    48.3   85     13.0

  **Race or ethnicity**                                                                                                                                                      

  \                                         American Indian or Alaska Native                                   2      0.1    0     0      0      0      2      100    0      0

  \                                         Asian                                                              20     0.6    0     0      1      5.0    17     85.0   2      10.0

  \                                         Black or African American                                          1526   47.3   112   7.3    239    15.7   1030   67.5   145    9.5

  \                                         Hispanic or Latino^g^                                              717    22.2   43    6      124    17.3   483    67.4   67     9.3

  \                                         Native Hawaiian or other Pacific Islander                          3      0.1    0     0      0      0      2      66.7   1      33.3

  \                                         White                                                              751    23.3   74    9.9    143    19.0   432    57.5   102    13.6

  \                                         Multiple races                                                     204    6.3    15    7.4    35     17.2   138    67.6   16     7.8

  **Transmission category^h^**                                                                                                                                               

  \                                         Male-to-male sexual contact (MSM^i^)                               1315   40.8   98    7.4    216    16.4   854    65.0   148    11.2

  \                                         Male injection drug use                                            513    15.9   43    8.3    86     16.8   333    64.7   52.7   10.3

  \                                         Female injection drug use                                          305    9.5    26    8.5    63     20.5   189    61.8   28     9.2

  \                                         MSM^i^ and injection drug use                                      251    7.8    19    7.6    48     19.2   154    61.4   30     11.8

  \                                         Male heterosexual contact                                          271    8.4    12    4.4    42     15.4   188    69.3   30     10.9

  \                                         Female heterosexual contact                                        521    16.2   42    8.0    81     15.4   359    68.9   40     7.6

  \                                         Other                                                              47     1.4    6     11.8   7      15.3   28     60.9   6      12.0

  **Ever AIDS**                                                                                                                                                              

  \                                         Yes                                                                2946   91.4   171   5.8    448    15.2   2104   71.4   223    7.6

  \                                         No                                                                 277    8.6    73    26.4   94     33.9   0      0      110    39.7
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Stage of disease within 12 months before death based on most recent CD4 test performed.

^b^HIV-attributable deaths were those for which HIV infection, AIDS-indicative opportunistic illness, or immunodeficiency was the underlying cause.

^c^CD4: CD4^+^T-lymphocyte count (cells/µL) or percentage.

^d^OI: opportunistic illness (ie, AIDS-defining condition).

^e^Column percent.

^f^Row percent.

^g^Hispanic or Latino can be of any race.

^h^Data on transmission category statistically adjusted to account for missing transmission category.

^i^MSM: men who had sex with men.

###### 

Most recent stage of disease within 12 months before death, among persons aged ≥13 years who died of non--HIV-attributable causes in 2012.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Decedent characteristics                  Most recent stage^a^ of disease before non--HIV-attributable death^b^                                                                  
  ----------------------------------------- ----------------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  Total                                     3371                                                                    100    686    20.4   987    29.3   1041   30.9   657    19.5   

  **Sex**                                                                                                                                                                          

  \                                         Male                                                                    2493   74.0   482    19.3   741    29.7   782    31.4   488    19.6

  \                                         Female                                                                  878    26.0   204    23.2   246    28.0   259    29.5   169    19.2

  **Age (years) at death, year-end 2012**                                                                                                                                          

  \                                         13-29                                                                   74     2.2    16     21.6   17     23.0   20     27.0   21     28.4

  \                                         30-39                                                                   233    6.9    55     23.6   55     23.6   77     33.0   46     19.7

  \                                         40-49                                                                   786    23.3   163    20.7   208    26.5   264    33.6   151    19.2

  \                                         50-59                                                                   1292   38.3   259    20     393    30.4   416    32.2   224    17.3

  \                                         ≥60                                                                     986    29.2   193    19.6   314    31.8   264    26.8   215    21.8

  **Race or ethnicity**                                                                                                                                                            

  \                                         American Indian or Alaska Native                                        2      0.1    0      0      0      0      1      50.0   1      50.0

  \                                         Asian                                                                   17     0.5    3      17.6   7      41.2   5      29.4   2      11.8

  \                                         Black or African American                                               1536   45.6   294    19.1   452    29.4   481    31.3   309    20.1

  \                                         Hispanic or Latino^g^                                                   617    18.3   105    17.0   196    31.8   218    35.3   98     15.9

  \                                         Native Hawaiian or other Pacific Islander                               3      0.1    1      33.3   0      0      2      66.7   0      0

  \                                         White                                                                   978    29     230    23.5   262    26.8   264    27.0   222    22.7

  \                                         Multiple races                                                          218    6.5    53     24.3   70     32.1   70     32.1   25     11.5

  **Transmission category^h^**                                                                                                                                                     

  \                                         Male-to-male sexual contact (MSM^i^)                                    1240   36.8   263    21.2   371    29.9   373    30.1   234    18.8

  \                                         Male injection drug use                                                 677    20.0   110    16.3   202    29.9   226    33.5   138    20.4

  \                                         Female injection drug use                                               397    11.8   85     21.3   121    30.5   112    28.2   79     20.0

  \                                         MSM^i^ and injection drug use                                           287    8.5    56     19.6   85     29.5   94     32.8   52     18.1

  \                                         Male heterosexual contact                                               273    8.1    52     19.1   76     27.8   85     31.1   60     22.0

  \                                         Female heterosexual contact                                             471    14.0   118    24.9   122    26.0   143    30.4   88     18.8

  \                                         Other                                                                   27     0.8    3      11.7   11     39.6   7      26.7   6      22

  **Ever AIDS**                                                                                                                                                                    

  \                                         Yes                                                                     2564   76.1   401    15.6   779    30.4   1041   40.6   343    13.4

  \                                         No                                                                      807    23.9   285    35.3   208    25.8   0      0      314    38.9
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Stage of disease within 12 months before death based on most recent CD4 test performed.

^b^Non--HIV-attributable deaths were all deaths for which the underlying cause was known other than those for which the underlying cause was HIV disease, an AIDS-indicative opportunistic illness, or immunodeficiency.

^c^CD4: CD4^+^T-lymphocyte count (cells/µL) or percentage.

^d^OI: opportunistic illness (ie, AIDS-defining condition).

^e^Column percent.

^f^Row percent.

^g^Hispanic or Latino can be of any race.

^h^Data on transmission category statistically adjusted to account for missing transmission category.

^i^MSM: men who had sex with men.

Overall, 91.34% (2944/3223) and 82.74% (2789/3371) of persons who died of HIV-attributable or non--HIV-attributable causes, respectively, had care within 12 months before death (≥1 CD4 or viral load test; [Table 3](#table3){ref-type="table"}). The percentage of persons who received continuous care (≥2 CD4 or viral load tests, 3 months apart) was similar among persons who died of HIV-attributable and non--HIV-attributable causes (66.15%, 2132/3223 and 65.89%, 2221/3371, respectively; [Table 4](#table4){ref-type="table"}). The percentage of persons with viral suppression was substantially lower among those who died of HIV-attributable causes (33.76%, 1088/3223) than among those who died of non--HIV-attributable causes (50.96%, 1718/3371; adjusted prevalence ratio 0.69, 95% CI 0.65-0.73; [Table 4](#table4){ref-type="table"}). Prevalence of viral suppression for persons who ever had stage 3 (AIDS) was lower among those who died of HIV but did not differ by cause of death for persons who never had stage 3 (AIDS).

The percentages with ≥1 CD4 or viral load test was ≥74% for most demographic groups and transmission categories but somewhat lower for persons who never had stage 3 disease (AIDS; 69.0%, 191/277 and 64.7%, 522/807 among persons who died of HIV-attributable and non--HIV-attributable causes, respectively) and persons whose diagnosis of HIV infection was ≤12 months before their death due to non--HIV-attributable causes (67.8%, 124/183).The percentage of persons with viral suppression was lower in most demographic and behavioral groups of persons who died of HIV-attributable causes than in their counterparts of persons who died of other causes.

Most persons in this study had HIV infection diagnosed more than 5 years before death (2368/3223, 73.47% and 2762/3371, 81.93% among those who died of HIV-attributable and non--HIV-attributable causes, respectively; [Table 3](#table3){ref-type="table"}).

###### 

Care and viral suppression within 12 months before death, among persons aged ≥13 years, comparing those who died of HIV-attributable causes with those who died of non--HIV-attributable causes in 2012, in 13 US jurisdictions: "in care" (≥1 CD4 or viral load test).

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Decedent characteristics                  Total                                        ≥1 CD4 or VL^a^ test   Unknown if had CD4 or VL test                                                                           
  ----------------------------------------- -------------------------------------------- ---------------------- ------------------------------- ------ ------ ------ ------ ----------- ----------- ----- ------ ------ ------
  Total                                     3223                                         3371                   2944                            91.3   2789   82.7   1.05   1.03-1.06   279         8.7   582    17.0   

  **Sex**                                                                                                                                                                                                               

  \                                         Male                                         2374                   2493                            2159   90.9   2060   82.6   1.05        1.03-1.07   215   9.1    433    17.4

  \                                         Female                                       849                    878                             785    92.5   729    83.0   1.05        1.02-1.09   64    7.5    149    17.0

  **Age (years) at death, year-end 2012**                                                                                                                                                                               

  \                                         13-29                                        154                    74                              146    94.8   55     74.3   1.02        0.92-1.14   8     5.2    19     25.7

  \                                         30-39                                        396                    233                             371    93.7   193    82.8   1.02        0.97-1.07   25    6.3    40     17.2

  \                                         40-49                                        914                    786                             848    92.8   655    83.3   1.06        1.03-1.10   66    7.2    131    16.7

  \                                         50-59                                        1107                   1292                            999    90.2   1095   84.8   1.03        1.00-1.06   108   9.8    197    15.2

  \                                         ≥60                                          652                    986                             580    89.0   791    80.2   1.09        1.05-1.13   72    11.0   195    19.8

  **Race or ethnicity**                                                                                                                                                                                                 

  \                                         Black or African American                    1526                   1536                            1397   91.5   1254   81.6   1.05        1.02-1.08   129   8.5    282    18.4

  \                                         Hispanic or Latino^f^                        717                    617                             661    92.2   529    85.7   1.04        1.00-1.08   56    7.8    88     14.3

  \                                         White                                        751                    978                             671    89.3   790    80.8   1.07        1.03-1.11   80    10.7   188    19.2

  \                                         Other races                                  229                    240                             215    93.9   216    90.0   1.02        0.97-1.07   14    6.1    24     10.0

  **Transmission category^g^**                                                                                                                                                                                          

  \                                         Male-to-male sexual contact (MSM^h^)         1315                   1240                            1198   91.1   1041   84.0   1.03        1.01-1.06   117   8.9    199    16.0

  \                                         Male injection drug use                      513                    676                             470    91.6   548    81.1   1.08        1.03-1.12   43    8.4    128    18.9

  \                                         Female injection drug use                    305                    397                             281    92.0   327    82.2   1.08        1.02-1.14   24    7.9    70     17.6

  \                                         MSM^h^ and injection drug use                251                    287                             225    89.6   240    83.7   1.05        0.98-1.12   26    10.4   47     16.4

  \                                         Male heterosexual contact                    271                    273                             246    90.6   215    79.1   1.06        1.00-1.12   25    9.2    58     21.2

  \                                         Female heterosexual contact                  521                    471                             486    93.2   394    83.6   1.04        0.99-1.08   35    6.7    77     16.3

  \                                         Other                                        47                     27                              39     83.9   23     85.3   0.93        0.77-1.12   8     17.0   4      14.8

  **Ever AIDS**                                                                                                                                                                                                         

  \                                         Yes                                          2946                   2564                            2753   93.4   2267   88.4   1.05        1.03-1.06   193   6.6    297    11.6

  \                                         No                                           277                    807                             191    69.0   522    64.7   1.05        0.96-1.16   86    31.0   285    35.3

  **Time since HIV diagnosis**                                                                                                                                                                                          

  \                                         ≤12 months                                   450                    183                             410    91.1   124    67.8   1.34        1.21-1.49   40    8.9    59     32.2

  \                                         13-24 months                                 108                    93                              100    92.6   77     82.8   1.12        1.00-1.24   8     7.4    16     17.2

  \                                         3-5 years                                    297                    333                             281    94.6   251    75.4   1.26        1.17-1.34   16    5.4    82     24.6

  \                                         More than 5 years                            2368                   2762                            2153   90.9   2337   84.6   1.07        1.04-1.09   215   9.1    425    15.4

  **MSA^i^** **at diagnosis**                                                                                                                                                                                           

  \                                         MSA (population ≥500,000)                    2688                   2937                            2468   91.8   2445   83.2   1.05        1.03-1.07   220   8.2    492    16.8

  \                                         MSA (population 50,000-499,999)              397                    337                             352    88.7   268    79.5   1.07        1.01-1.13   45    11.3   69     20.5

  \                                         Nonmetropolitan area (population \<50,000)   128                    81                              115    89.8   66     81.5   0.98        0.91-1.05   13    10.2   15     18.5

  \                                         Unknown                                      10                     16                              9      90.0   10     62.5   \-          \           1     10.0   6      37.5
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^VL: viral load (copies/mL).

^b^HIV deaths (HIV-attributable deaths) were those for which HIV infection, AIDS-indicative opportunistic illness, or immunodeficiency was the underlying cause of death.

^c^Non-HIV deaths (non--HIV-attributable deaths) were all other deaths for which the underlying cause was known.

^d^APR: adjusted prevalence ratio, adjusted for sex, age at death, race/ethnicity, transmission category, and ever AIDS.

^e^CI: confidence interval

^f^Hispanic or Latino can be of any race.

^g^Data on transmission category have been statistically adjusted to account for missing transmission category.

^h^MSM: Men who had sex with men.

^i^MSA: metropolitan statistical area.

###### 

Care and viral suppression within 12 months before death, among persons aged ≥13 years, comparing those who died of HIV-attributable causes with those who died of non--HIV-attributable causes in 2012, in 13 US jurisdictions: "in continuous care" (≥2 CD4 or viral load tests at least 3 months apart).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Decedent characteristics                  ≥2 CD4 or VL^a^ test at least 3 months apart   VL \<200 copies/mL                                                                                        
  ----------------------------------------- ---------------------------------------------- -------------------- ------ ------ ------ ----------- ----------- ------ ------ ------ ------ ----------- -----------
  Total                                     2132                                           66.1                 2221   65.9   0.96   0.92-0.99   1088        33.8   1718   51.0   0.69   0.65-0.73   

  **Sex**                                                                                                                                                                                            

  \                                         Male                                           1532                 64.5   1642   65.9   0.93        0.89-0.97   843    35.5   1324   53.1   0.69        0.64-0.74

  \                                         Female                                         600                  70.7   579    65.9   0.99        0.93-1.06   245    28.9   394    44.9   0.69        0.61-0.79

  **Age (years) at death, year-end 2012**                                                                                                                                                            

  \                                         13-29                                          97                   63.0   41     55.4   0.94        0.72-1.23   34     22.1   20     27.0   1.12        0.60-2.09

  \                                         30-39                                          248                  62.6   129    55.4   0.99        0.86-1.15   69     17.4   98     42.1   0.42        0.32-0.56

  \                                         40-49                                          607                  66.4   497    63.2   0.97        0.90-1.04   284    31.1   361    45.9   0.67        0.59-0.76

  \                                         50-59                                          750                  67.8   888    68.7   0.95        0.90-1.00   396    35.8   672    52.0   0.66        0.60-0.73

  \                                         ≥60                                            430                  66.0   666    67.5   0.95        0.88-1.01   305    46.8   567    57.5   0.8         0.73-0.89

  **Race or ethnicity**                                                                                                                                                                              

  \                                         Black or African American                      1055                 69.1   987    64.3   1.01        0.96-1.06   453    29.7   678    44.1   0.71        0.64-0.78

  \                                         Hispanic or Latino^f^                          464                  64.7   459    74.4   0.89        0.83-0.96   245    34.2   353    57.2   0.63        0.56-0.72

  \                                         White                                          458                  61.0   600    61.3   0.97        0.90-1.05   309    41.1   559    57.2   0.72        0.65-0.80

  \                                         Other races                                    155                  67.7   175    72.9   0.9         0.80-1.00   81     35.4   128    53.3   0.7         0.57-0.87

  **Transmission category^g^**                                                                                                                                                                       

  \                                         Male-to-male sexual contact (MSM^h^)           813                  61.8   806    65.0   0.9         0.85-0.96   456    34.7   696    56.1   0.65        0.59-0.71

  \                                         Male injection drug use                        362                  70.6   459    68.0   1.01        0.94-1.08   202    39.4   349    51.6   0.78        0.69-0.89

  \                                         Female injection drug use                      230                  75.3   268    67.5   1.05        0.96-1.16   94     30.7   181    45.5   0.72        0.59-0.88

  \                                         MSM^h^ and injection drug use                  171                  68.2   199    69.3   0.95        0.84-1.06   92     36.7   161    56.2   0.66        0.54-0.81

  \                                         Male heterosexual contact                      171                  63.3   167    61.2   0.95        0.84-1.08   82     30.3   109    40.0   0.79        0.62-1.00

  \                                         Female heterosexual contact                    354                  68.0   303    64.4   0.95        0.87-1.04   142    27.3   209    44.5   0.65        0.54-0.78

  \                                         Other                                          30                   65.2   18     65.6   0.86        0.63-1.18   19     41.7   13     48.7   1.08        0.61-1.94

  **Ever AIDS**                                                                                                                                                                                      

  \                                         Yes                                            1986                 67.4   1848   72.1   0.94        0.91-0.98   970    32.9   1395   54.4   0.66        0.62-0.71

  \                                         No                                             146                  52.7   373    46.2   1.13        0.99-1.29   118    42.6   323    40.0   1.05        0.90-1.23

  **Time since HIV diagnosis**                                                                                                                                                                       

  \                                         ≤12 months                                     116                  25.8   48     26.2   0.97        0.73-1.30   80     17.8   31     16.9   0.89        0.59-1.34

  \                                         13-24 months                                   75                   69.4   66     71.0   0.99        0.80-1.22   39     36.1   46     49.5   0.68        0.47-0.98

  \                                         3-5 years                                      193                  65.0   181    54.4   1           0.88-1.14   103    34.7   139    41.7   0.9         0.72-1.12

  \                                         More than 5 years                              1748                 73.8   1926   69.7   1.02        0.99-1.06   866    36.6   1502   54.4   0.71        0.67-0.76

  **MSA^i^** **at diagnosis**                                                                                                                                                                        

  \                                         MSA (population ≥500,000)                      1816                 67.6   1977   67.3   0.96        0.93-1.00   941    35.0   1520   51.8   0.7         0.66-0.75

  \                                         MSA (population 50,000-499,999)                230                  57.9   189    56.1   0.95        0.83-1.08   108    27.2   144    42.7   0.69        0.56-0.86

  \                                         Nonmetropolitan area (population \<50,000)     79                   61.7   47     58.0   0.9         0.72-1.11   36     28.1   48     59.3   0.43        0.31-0.60

  \                                         Unknown                                        7                    70.0   8      50.0   \-          \           3      30.0   6      37.5   \-          \
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^VL: viral load (copies/mL).

^b^HIV deaths (HIV-attributable deaths) were those for which HIV infection, AIDS-indicative opportunistic illness, or immunodeficiency was the underlying cause of death.

^c^Non-HIV deaths (non--HIV-attributable deaths) were all other deaths for which the underlying cause was known.

^d^APR: adjusted prevalence ratio, adjusted for sex, age at death, race/ethnicity, transmission category, and ever AIDS.

^e^CI: confidence interval

^f^Hispanic or Latino can be of any race.

^g^Data on transmission category have been statistically adjusted to account for missing transmission category.

^h^MSM: men who had sex with men.

^i^MSA: metropolitan statistical area.

^j^Total HIV and non-HIV deaths (denominators) are shown in [Table 3](#table3){ref-type="table"}.

Discussion
==========

Principal Findings
------------------

Our results indicated poorer outcome in terms of viral suppression in the last 12 months before death among persons who died of HIV-attributable causes, consistent with other studies \[[@ref9]\]. Almost two-thirds (65.28%) of persons who died of HIV-attributable causes had late-stage disease (stage 3, AIDS) in the 12 months before death, compared with 30.88% of those who died of other causes, and the percentage with a suppressed viral load was lower among persons who died of HIV-attributable causes (33.76%) than among those who died of other causes (50.96%). This association between death due to HIV-attributable causes and both late-stage disease and lack of viral suppression could be explained by the latter two conditions being characteristic of late (delayed) diagnosis of HIV infection, inadequate care and treatment, inadequate adherence to medication regimens, or treatment failure \[[@ref9],[@ref10]\].

Although a high percentage of persons who died received care, a low percentage of them had viral suppression, particularly among persons who died of HIV-attributable causes. This is consistent with other studies \[[@ref9],[@ref10]\]. Although receipt of care might be expected to lead to viral suppression, the causal relationship may actually be in the reverse direction---being "in care" or "in continuous care," as measured by frequency of CD4 or viral load tests, could be a marker for clinical deterioration with high viral loads, due to lack of adherence or treatment failure, which then resulted in more frequent care.

Limitations
-----------

Our analyses were subject to some limitations. First, our analyses were based on data from 13 jurisdictions, representing 41% of all persons 13 years and older who died in 2012 in the United States, and, therefore, may not be representative of all persons with HIV who died in the United States. Second, cause of death information from death certificates may underestimate deaths due to HIV \[[@ref11],[@ref12]\]. The finding that a substantial percentage (30.88%) of the persons who died of non--HIV-attributable causes had stage 3 (AIDS) suggests that some of these deaths might actually have been HIV-attributable. Conversely, HIV infection may have been characterized as underlying cause of death for some patients without actually playing a role in their death if the physicians who certified the deaths ignored the instructions on the death certificate to list as causes only those conditions that "resulted in" or "contributed to" death, or incorrectly assumed that HIV infection did so. Third, information was not available on highly active antiretroviral therapy (HAART) or treatment adherence. Fourth, CD4 and viral load testing may not adequately capture the full spectrum of HIV care in the last 12 months before death \[[@ref5]\].

Conclusions
-----------

HAART has prolonged the survival of HIV-infected persons by reducing deaths due to HIV-attributable causes \[[@ref13]\]. To further decrease mortality, HIV-infected persons should seek early testing and, when diagnosed, be linked to care as soon as possible and be retained in such care so as to reduce the risk of death due to HIV and enable persons with HIV to have a life expectancy similar to that of persons without HIV \[[@ref13]\]. This is in consonance with the recommendation by the Panel on Antiretroviral Guidelines for Adults and Adolescents that diagnosis of HIV be made early in the course of infection so as to initiate therapy early and at any CD4 count \[[@ref14],[@ref15]\].
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HAART

:   highly active antiretroviral therapy

HIV

:   human immunodeficiency virus

ICD-10

:   International Classification of Diseases, Tenth Revision

MSM

:   men who had sex with men

NHSS

:   National HIV Surveillance System
